222 related articles for article (PubMed ID: 26147923)
1. Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.
Archary D; Liebenberg LJ; Werner L; Tulsi S; Majola N; Naicker N; Dlamini S; Hope TJ; Samsunder N; Abdool Karim SS; Morris L; Passmore JA; Garrett NJ
PLoS One; 2015; 10(7):e0131906. PubMed ID: 26147923
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.
Sha BE; D'Amico RD; Landay AL; Spear GT; Massad LS; Rydman RJ; Warner NA; Padnick J; Ackatz L; Charles LA; Benson CA
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):161-8. PubMed ID: 9390567
[TBL] [Abstract][Full Text] [Related]
3. Lower genital tract cytokine profiles in South African women living with HIV: influence of mucosal sampling.
Jaumdally SZ; Masson L; Jones HE; Dabee S; Hoover DR; Gamieldien H; Langwenya N; Myer L; Todd CS; Passmore JS
Sci Rep; 2018 Aug; 8(1):12203. PubMed ID: 30111808
[TBL] [Abstract][Full Text] [Related]
4. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of methods for collection and measurement of cytokines and immunoglobulins in cervical and vaginal secretions of HIV and HPV infected women.
Snowhite IV; Jones WE; Dumestre J; Dunlap K; Braly PS; Hagensee ME
J Immunol Methods; 2002 May; 263(1-2):85-95. PubMed ID: 12009206
[TBL] [Abstract][Full Text] [Related]
6. Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.
Mestecky J; Wright PF; Lopalco L; Staats HF; Kozlowski PA; Moldoveanu Z; Alexander RC; Kulhavy R; Pastori C; Maboko L; Riedner G; Zhu Y; Wrinn T; Hoelscher M
AIDS Res Hum Retroviruses; 2011 May; 27(5):469-86. PubMed ID: 21091128
[TBL] [Abstract][Full Text] [Related]
7. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.
Dezzutti CS; Hendrix CW; Marrazzo JM; Pan Z; Wang L; Louissaint N; Kalyoussef S; Torres NM; Hladik F; Parikh U; Mellors J; Hillier SL; Herold BC
PLoS One; 2011; 6(8):e23136. PubMed ID: 21858008
[TBL] [Abstract][Full Text] [Related]
8. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of HIV-1-specific IgG, IgA, and IgM antibodies in human genital tract secretions.
Haimovici F; Mayer KH; Anderson DJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):185-91. PubMed ID: 9257652
[TBL] [Abstract][Full Text] [Related]
10. Brief Report: The Anti-HIV-1 ADCC-Mediating Antibodies From Cervicovaginal Secretions of HIV-Infected Women Have an Ability to Mediate Lysing of Autologous CD4+ HIV-Infected Cells.
Dhande J; Angadi M; Murugavel KG; Poongulali S; Nandagopal P; Vignesh R; Ghate M; Kulkarni S; Thakar M
J Acquir Immune Defic Syndr; 2018 Oct; 79(2):277-282. PubMed ID: 30211779
[TBL] [Abstract][Full Text] [Related]
11. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.
Ghosh M; Fahey JV; Shen Z; Lahey T; Cu-Uvin S; Wu Z; Mayer K; Wright PF; Kappes JC; Ochsenbauer C; Wira CR
PLoS One; 2010 Jun; 5(6):e11366. PubMed ID: 20614007
[TBL] [Abstract][Full Text] [Related]
12. Optimising the collection of female genital tract fluid for cytokine analysis in pregnant women.
Short CS; Quinlan R; Bennett P; Shattock RJ; Taylor GP
J Immunol Methods; 2018 Jul; 458():15-20. PubMed ID: 29625077
[TBL] [Abstract][Full Text] [Related]
13. Genital self-sampling compared with cervicovaginal lavage for the diagnosis of female genital schistosomiasis in Zambian women: The BILHIV study.
Sturt AS; Webb EL; Phiri CR; Mweene T; Chola N; van Dam GJ; Corstjens PLAM; Wessels E; Stothard JR; Hayes R; Ayles H; Hansingo I; van Lieshout L; Bustinduy AL
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008337. PubMed ID: 32663222
[TBL] [Abstract][Full Text] [Related]
14. The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
Chappell CA; Isaacs CE; Xu W; Meyn LA; Uranker K; Dezzutti CS; Moncla BJ; Hillier SL
Am J Obstet Gynecol; 2015 Aug; 213(2):204.e1-6. PubMed ID: 25818668
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.
Bélec L; Tévi-Bénissan C; Dupré T; Mohamed AS; Prazuck T; Gilquin J; Kanga JM; Pillot J
J Clin Immunol; 1996 Jan; 16(1):12-20. PubMed ID: 8926281
[TBL] [Abstract][Full Text] [Related]
16. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers.
Kaul R; Trabattoni D; Bwayo JJ; Arienti D; Zagliani A; Mwangi FM; Kariuki C; Ngugi EN; MacDonald KS; Ball TB; Clerici M; Plummer FA
AIDS; 1999 Jan; 13(1):23-9. PubMed ID: 10207541
[TBL] [Abstract][Full Text] [Related]
17. Cervicovaginal Immune Activation in Zambian Women With Female Genital Schistosomiasis.
Sturt AS; Webb EL; Patterson C; Phiri CR; Mweene T; Kjetland EF; Mudenda M; Mapani J; Mutengo MM; Chipeta J; van Dam GJ; Corstjens PLAM; Ayles H; Hayes RJ; Hansingo I; Cools P; van Lieshout L; Helmby H; McComsey GA; Francis SC; Bustinduy AL
Front Immunol; 2021; 12():620657. PubMed ID: 33737927
[TBL] [Abstract][Full Text] [Related]
18. Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface.
Shacklett BL; Cu-Uvin S; Beadle TJ; Pace CA; Fast NM; Donahue SM; Caliendo AM; Flanigan TP; Carpenter CC; Nixon DF
AIDS; 2000 Sep; 14(13):1911-5. PubMed ID: 10997394
[TBL] [Abstract][Full Text] [Related]
19. Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood.
Haddad LB; Swaims-Kohlmeier A; Mehta CC; Haaland RE; Brown NL; Sheth AN; Chien H; Titanji K; Achilles SL; Lupo D; Hart CE; Ofotokun I
PLoS One; 2020; 15(3):e0230473. PubMed ID: 32214321
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities.
Seaton KE; Ballweber L; Lan A; Donathan M; Hughes S; Vojtech L; Moody MA; Liao HX; Haynes BF; Galloway CG; Richardson BA; Karim SA; Dezzutti CS; McElrath MJ; Tomaras GD; Hladik F
PLoS One; 2014; 9(7):e101863. PubMed ID: 25054205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
